Available Technology

Breast Cancer Detection, Digital Sensor

The BioScan System was developed by OmniCorder Technologies, Inc. at the Jet Propulsion Laboratory. The system is able to locate cancerous lesions by detecting the cancer's ability to recruit a new blood supply. A digital sensor detects infrared energy emitted from the body and identifies the minute differences accompanying the blood flow changes associated with cancerous cells. It also has potential use as a monitoring device during cancer treatment. This technology will reduce the time taken to detect cancerous cells and allow for earlier intervention, therefore increasing the overall survival rates of breast cancer patients.
Internal Laboratory Ref #: 
JPL-SO-90
Patent Status: 
Agency
NASA
Region
Far West
State: 
California
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin